Locations
England, UK · Cambridge, UK · Streetly End, Cambridge CB21 4RP, UK
industry
Biotechnology
Size
51-200 employees
Stage
Other
founded in
2016
Bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of Bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
Is this your company?
Something looks off?